Tag: Ebola
Eyes of Ebola Survivors Show Localized Pathological Changes
Retinal lesions mainly non-pigmented, pale gray with perilesional areas of dark without pressure
Vaccines Elicit Lasting Immune Response Against Ebola
ChAd3-EBO-Z, rVSVΔG-ZEBOV-GP vaccines elicit response that is maintained through 12 months
Novel Retinal Lesion Seen in Some Ebola Survivors
Novel retinal lesion following anatomical distribution of optic nerve axons seen in 14.6 percent of survivors
Immune Responses to Ebola Vaccines Persist at One Year
All active vaccine recipients maintained Ebola virus-specific immunoglobulin responses at day 360
HIV Coinfection May Play Role in Survival of Ebola RNA in Semen
Case report of EVD survivor with preexisting HIV whose semen was positive 565 days after recovery
Blood Test May Predict Survival for Patients With Ebola
Findings might lead to more effective patient care, researchers suggest
Recombinant Type-5 Vector-Based Ebola Vaccine Safe
Vaccine is immunogenic in healthy adults from Sierra Leone; optimal dose 8.0 × 1010 viral particles
Ebola Virus Lingers in Semen Longer Than Expected
And virus is more likely to be found in male survivors older than 40, researchers report
